Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.
about
Structural Basis of Regulation of von Willebrand Factor Binding to Glycoprotein IbWhat have we learned from large population studies of von Willebrand disease?Misfolding of vWF to pathologically disordered conformations impacts the severity of von Willebrand diseaseCommon VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.von Willebrand factor, Jedi knight of the bloodstreamThird Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity.Rapid discrimination of the phenotypic variants of von Willebrand disease.Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease.Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD.Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders.Pitfalls in special coagulation testing: three illustrative case studies.Technological advances in diagnostic testing for von Willebrand disease: new approaches and challenges.Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH.Developments in the diagnostic procedures for von Willebrand disease.A diagnostic approach to mild bleeding disorders.Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway.Evaluation of an automated von Willebrand factor activity assay in von Willebrand disease.Clinical and laboratory phenotype variability in type 2M von Willebrand disease.Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity.Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination.Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination.
P2860
Q27681197-E28E1A69-0FB2-44A8-96A7-04C87501A4FEQ30240214-0C780882-7BE7-4318-AC6D-9C0624EB8CC3Q33417479-0CFF45C3-3C15-4A7E-8499-8A7BAA567E88Q34022444-0E2ADFC6-1B91-42F0-97A9-9F9E0AB9B3FFQ34106824-22E4451F-1749-466A-9144-C1FE30C5B807Q34185963-273179B2-BF63-4E6C-958F-69CA907860F4Q34667787-4BB32489-ADC6-44ED-AB56-A16F9C823081Q34816051-6E3F7335-C6D0-4906-B81A-1FBDD5F66B62Q36742828-9F6B86DA-9540-400F-AAAF-413E2FC75C1BQ36920458-30650FA7-2EEB-441B-8C9D-37392BC412E2Q36944971-D06DB31A-B2C8-4FF4-882A-0005C6B1C322Q37480494-4D0C17C3-C855-4155-B724-E1D1A2DD3FAFQ38020976-127377D5-83EC-4452-902F-80DAF20B034CQ38088422-C7010991-E6FE-4CB2-B8DB-310D3A6FF2CDQ38205952-2A743B65-5FB6-4F8F-9339-A3B85ACA2C64Q38413638-4BBACD82-E193-41AD-9B45-8CC0E9AEFEA5Q38682256-75A00C81-FAFE-4F36-8D4E-30E900FD9B3FQ38840603-E6BFEA9D-F1BF-43B4-976A-C38F6B7BE59EQ43801561-00C97311-88AA-482C-95CC-124142B109A9Q45862976-D19449C7-26D7-4DFE-B8F5-4F67D0605C76Q45868176-B67AC714-4BEE-444E-9E0B-44ADD379405BQ45873596-E5FDA58B-D3E9-46CE-9EE7-ACB46388DA9EQ45877995-FF3AC9B9-8E90-4589-AA2B-0B4DFC451310Q45887986-CA801949-0C66-431C-ADB2-D8E4FC9E4A89Q48152338-564E83A0-BEEF-4991-9BE1-E5FCB733A16BQ51202855-B09E3A1D-98EC-41D0-9B29-AAA84CEADE82
P2860
Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Limitations of the ristocetin ...... on Willebrand factor function.
@en
Limitations of the ristocetin ...... on Willebrand factor function.
@nl
type
label
Limitations of the ristocetin ...... on Willebrand factor function.
@en
Limitations of the ristocetin ...... on Willebrand factor function.
@nl
prefLabel
Limitations of the ristocetin ...... on Willebrand factor function.
@en
Limitations of the ristocetin ...... on Willebrand factor function.
@nl
P2093
P2860
P1476
Limitations of the ristocetin ...... on Willebrand factor function.
@en
P2093
K D Friedman
P A Morateck
R R Montgomery
P2860
P304
P356
10.1111/J.1538-7836.2009.03594.X
P577
2009-08-19T00:00:00Z